Open an Account
search icon
2
NOTIFICATIONS
Best Algo trading app in India
Bigul

Eiko Lifesciences Ltd - 540204 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to Reg. 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached scanned copy of the newspaper publication of Audited Financial Results of the Company for the quarter and year ended March 31, 2023, duly approved in the Board Meeting held on May 09, 2023, published in the Financial Express (in English) and Mumbai Lakshadweep (in Marathi).
10-05-2023
Bigul

Annual report for Eiko Lifesciences Ltd. for FY-2023
10-05-2023
Bigul

Eiko Lifesciences Ltd - 540204 - Related Party Transactions For The Half Year Ended March 31, 2023

 Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed disclosure of Related Party Transactions for the half year ended March 31, 2023.
09-05-2023
Bigul

Eiko Lifesciences Ltd - 540204 - Announcement under Regulation 30 (LODR)-Investor Presentation

 Investor Presentation on Financials Results for quarter and year ended 31st March 2023
09-05-2023
Bigul

Eiko Lifesciences Ltd - 540204 - Financial Results For Quarter And Year Ended March 31, 2023

 The Board of Directors of Eiko LifeSciences Limited at its Meeting held today i.e. May 09, 2023, has inter-alia approved the Audited Financial Results for the quarter and year ended March 31, 2023
09-05-2023
Bigul

Eiko Lifesciences Ltd - 540204 - Board Meeting Outcome for Outcome Of Board Meeting Of Eiko Lifesciences Limited Held On May 09, 2023

 The Board Considered, approved and taken on record the following: 1. Audited Financial Results of the Company for the Quarter and year ended 31st March 2023 along with Auditor's Report duly signed by the Auditor of the Company . 2. Appointment of M/s Shravan Gupta & Associates, Practicing Company Secretary, as Secretarial Auditor for financial year 2023-24. 3. Appointment of M/s NP Rajput & Co., Chartered accountant, as Internal Auditor for financial year 2023-24.
09-05-2023
Bigul

Eiko Lifesciences Ltd - 540204 - Board Meeting Intimation for Considering The Audited Financial Results Of The Company Along With Audit Report For The Quarter And Year Ended 31St March 2023.

 Eiko Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/05/2023 ,inter alia, to consider and approve Audited Financial Results of the Company along with Audit Report for the quarter and year ended 31st March 2023.
29-04-2023
Bigul

Eiko Lifesciences Ltd - 540204 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

 Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyEiko Lifesciences Ltd 2CIN NO.L65993MH1977PLC258134 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.05 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Avi Mundecha Designation: Company Secretary and Compliance Officer EmailId: [email protected] Name of the Chief Financial Officer: Jaid Ismail Kojar Designation: Cheif Financial Officer EmailId: [email protected] Date: 17/04/2023 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
17-04-2023
Bigul

Eiko Lifesciences Ltd - 540204 - Certificate Under Reg.40 (9) Of SEBI (LODR) Regulations, 2015 For The Year Ended 31St March, 2023

 Pursuant to Regulation 40 (10) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclosed the Certificate for the year ended 31st March, 2023 issued by Shravan A. Gupta & Associates, Practicing Company Secretary, for the year ended 31.3.2023 in compliance with Regulation 40 (9) of the above-mentioned Regulations, for your information and record.
08-04-2023
Bigul

Eiko Lifesciences Ltd - 540204 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the Quarter ended March 31, 2023
06-04-2023
Next Page
Close

Let's Open Free Demat Account